Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,285
datasets available to search
ShareScore release 0.9.0
Dataset results
2,285 results for “T-cells”
Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)
ClinicalTrials.gov study NCT00491556. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Ruxolitinib Phosphate to Treat Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Stem Cell Transplant
ClinicalTrials.gov study NCT01431209. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies
ClinicalTrials.gov study NCT04447027. IPD Sharing: YES. Countries: 1. Publications: 0.
Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidenti
ClinicalTrials.gov study NCT00967343. IPD Sharing: Not stated. Countries: 7. Publications: 2.
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
ClinicalTrials.gov study NCT02112916. IPD Sharing: Not stated. Countries: 4. Publications: 3.
Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS
ClinicalTrials.gov study NCT00025662. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT03573700. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma
ClinicalTrials.gov study NCT00426764. IPD Sharing: Not stated. Countries: 10. Publications: 7.
A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas
ClinicalTrials.gov study NCT00274651. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies
ClinicalTrials.gov study NCT02706392. IPD Sharing: NO. Countries: 1. Publications: 2.
Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
ClinicalTrials.gov study NCT01351025. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia
ClinicalTrials.gov study NCT00117845. IPD Sharing: NO. Countries: 1. Publications: 3.
Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome
ClinicalTrials.gov study NCT04185220. IPD Sharing: NO. Countries: 1. Publications: 2.
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma
ClinicalTrials.gov study NCT03113500. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma
ClinicalTrials.gov study NCT00211185. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma
ClinicalTrials.gov study NCT01871727. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Study for Participants With Relapsed Cutaneous T-Cell Lymphoma
ClinicalTrials.gov study NCT00744991. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHL
ClinicalTrials.gov study NCT00274742. IPD Sharing: Not stated. Countries: 1. Publications: 2.
O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma
ClinicalTrials.gov study NCT00961220. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma
ClinicalTrials.gov study NCT00061048. IPD Sharing: Not stated. Countries: 1. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.